abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, and concerns a method of treating a patient having a non-small cell lung cancer with ALK translocation involving administering a therapeutically effective amount of ceritinib in a combination with nivolumab to said patient.EFFECT: invention provides immune response modulation.1 cl, 1 dwg, 2 tbl, 3 ex |